Article

EnVision Summit 2023: The what, whys, and hows of corneal neurotization

Author(s):

Corneal neurotization is an efficacious procedure to restore sensation to a neurotrophic cornea, involving the surgical transfer of sensory nerve fibers to the cornea.

Glasses sitting on a sheet of paper with colorful images of a cornea topography

Healthy corneal nerves function to ensure the health of the corneal tissue. (Image courtesy stock.adobe.com)

Corneal neurotization is an efficacious procedure to restore sensation to a neurotrophic cornea. The procedure involves surgical transfer of sensory nerve fibers to the cornea, according to Andrea Lora Kossler, MD, FACS., Director, Oculofacial Plastic and Reconstructive Surgery, Co-Director, Multi-Disciplinary Thyroid Eye Disease Clinic, Associate Professor of Ophthalmology, Byers Eye Institute at Stanford University, Stanford School of Medicine, Palo Alto, CA.

Dr. Kossler reported on the topic at the Envision Summit in Puerto Rico.

The principles of corneal neurotization are that healthy corneas require nerve input, neurotization repairs a denervated target using healthy nerve axons, and the peripheral nerves have the ability to regenerate.

Healthy corneal nerves function to ensure the health of the corneal tissue. They evoke blinking and tearing reflexes, release neuropeptides, and are critical to the integrity of the epithelial cells, which release neurotrophic growth factors that are crucial for corneal nerve function. “Without sensory nerve input, neurotrophic keratopathy develops,” she stated.

How neurotization works

“We know that peripheral nerves regenerate when cut or damaged, as do axons by direct and indirect transfer,” she explained.

The selection of donor nerves depends on the nerve size and axon numbers, nerve proximity, donor site morbidity, and finally the surgeon's comfort level.

The common sensory donor nerves include the supraorbital, supratrochlear, infraorbital, and great auricular nerves. She explained that the supraorbital nerve exits at the superior orbital rim lateral to the supratrochlear nerve and has a larger caliber. The deep branch of the supraorbital nerve has a more consistent course. The contralateral or ipsilateral donor sensory nerves can be selected depending on the availability and condition of the sensate nerves.”

Dr. Kossler reported the primary outcomes of corneal neurotization performed in 70 eyes from 2008 to 2020.1

The results showed that patients had significant (p < 0.001 for both comparisons) improvements in visual acuity and in corneal sensation by 37.94 millimeters. The maximal corneal sensation was measured at 9 months (range, 6-18.5 months).

Dr. Kossler concluded, “Corneal neurotization is safe and effective effect for treating neurotrophic keratopathy that can restore corneal sensation, wound healing, and improve vision. The long-term results show anatomic evidence of nerve regeneration and clinical efficacy.”

Andrea Lora Kossler, MD, FACS

Andrea Lora Kossler, MD, FACS

Andrea Lora Kossler, MD, FACS
Kossler is the Director of Oculofacial Plastic and Reconstructive Surgery, Co-Director of Multi-Disciplinary Thyroid Eye Disease Clinic, an Associate Professor of Ophthalmology at Byers Eye Institute at Stanford University, Stanford School of Medicine, Palo Alto, CA.
Reference
1. Lenygold IM, Kossler AL, Yen MT. Techniques in corneal neurotization. St. Louis: Quality Medical Publishing, 2020.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.